Logo

Kopran Ltd. Share Price

Pharmaceuticals & Drugs

Kopran Ltd. (INR)186.10.1   (0%)

Exchange ScripsBSE524280NSEKOPRANISININE082A01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Kopran Ltd. Performance

Market performance

Open price187.25
High190.5
Volumes250551
Prev Close186.1
Low184.04
Closing date2025-05-20

Historical performance

1 Year High369.70
3 Year High369.70
5 Year High370.45
1 Year Low155.00
3 Year Low96.00
5 Year Low26.10

Kopran Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
905
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
17.61
Dividend Yield
Dividend Yield
0.16 %

Kopran Ltd. Investment Returns

1 Year
-25.3%
3 Years
-18.1%
5 Years
641.4%
10 Years
245.6%

Kopran Ltd. Technicals

IndicatorsValueSignal
5-DMA186.86Bearish
10-DMA184.94Bullish
20-DMA189.35Bearish
50-DMA183.91Bullish
100-DMA188.39Bearish
200-DMA234.73Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters1819202021
Foreign Investors---------------
Domestic Investors1819202021
Public Investors5863360540571335147250829
Government---------------

Kopran Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income14731108182
Operating Profit890549980998
Interest86615162
Depreciation129127111102
Profit Before Tax675361818833
Consolidated Net Profit510272610616
Adjusted EPS1161314

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital482482482433
Total Reserves4420391037802018
Minority Interest------------
Total Non-Current Liabilities335335331337
Total Liabilities7432649761094394
Capital Work in Progress777557275371
Total Assets7432649761094394

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities433340-335600
Cash Flow from Investing Activities-436-127-844-253
Cash Flow from Financing Activitie10-1981228-346
Net Cash Inflow / Outflow715491
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.61.
  • 3Y Stock Price CAGR of the stock is -6.1.
  • The stock has a beta of 1.5.
  • In the last financial year, the company had an EBITDA of ₹890 Million.
  • The company generated revenue of ₹6146 Million in the previous financial year.

Kopran Ltd.

186.10.1   (0%)

Investment Amount: ₹ 1000000
Current Value: ₹ 763174.1
No. of Shares: 4100.9
Performance:-23.7%
P/L: ₹-236825.9

Top Gainers

SymbolChange%
TATVA906.3(20%)
HTMEDIA21.56(20%)
HLEGLAS362.6(20%)
KAPSTON255.72(20%)
HONDAPOWER2795.5(20%)

Top Losers

SymbolChange%
GANESHBE108.81(-15%)
QUESS338.35(-9%)
JAYNECOIND39.95(-9%)
DOMS2548.8(-9%)
PROTEAN1048.4(-8%)
COCHINSHIP1817.6(-8%)
BAIDFIN10.47(-8%)
BAJAJHLDNG12932(-8%)

Similar stocks

Suven Life Sciences Ltd.

62.8

205.64

April 20 - May 20

Kilitch Drugs (India) Ltd.

34.4

471.3

April 20 - May 20

Aarti Drugs Ltd.

31.2

468.95

April 20 - May 20

NGL Fine-Chem Ltd.

26.1

1311.8

April 20 - May 20

Anuh Pharma Ltd.

21.9

208.79

April 20 - May 20

SMS Pharmaceuticals Ltd.

21

262.55

April 20 - May 20

Morepen Laboratories Ltd.

20

62.83

April 20 - May 20

Themis Medicare Ltd.

19.2

160.12

April 20 - May 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month